PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
121 hedge funds and large institutions have $501M invested in Progenics Pharmaceuticals Inc in 2015 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 107 → 121 (+14)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
121
Holding in Top 10
1
Calls
$5.62M
Puts
$4.32M
Top Buyers
| 1 | +$12.2M | |
| 2 | +$11.3M | |
| 3 | +$6.07M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$4.17M |
| 5 |
PCM
Piermont Capital Management
St. Louis,
Missouri
|
+$2.62M |
Top Sellers
| 1 | -$7.71M | |
| 2 | -$6.87M | |
| 3 | -$5.27M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.89M |
| 5 |
Morgan Stanley
New York
|
-$2.8M |